Experiment 449387

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVO

Compounds isolated

STREPTOMYCES ANTIBIOTIC L-156602

Details

PropertyValue
Pharmacology
COMPLEMENT C5-A BINDING INHIBITION
Administration routeIP
OrganismStreptomyces species (STREPTOMYCETACEAE)
CitationTSUJI,RF: URAMOTO,M: KOSHINO,H: TSUJI,NM: MAGAE,J: NAGAI,K: YAMASAKI,M:. (1992). PREFERENTIAL SUPPRESSION OF DELAYED-TYPE HYPERSENSITIVITY BY L-156,602, A C5A RECEPTOR ANTAGONIST.. 56(10)
Amount utilized
Compound isolated
DiseaseACTIVITY REFERRED TO, NOT TESTED.
Number6
Qualitative resultACTIVE
AnimalMOUSE
Dose expressionDOSE